{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:03:00Z","timestamp":1785434580308,"version":"3.56.0"},"reference-count":47,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["Centre for Drug Safety Science G0700654"],"award-info":[{"award-number":["Centre for Drug Safety Science G0700654"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["MRC-CASE studentship grant number MR\/L006758\/1"],"award-info":[{"award-number":["MRC-CASE studentship grant number MR\/L006758\/1"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,6,5]]},"abstract":"<jats:sec id=\"abs1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Evidence supports an important link between mitochondrial DNA (mtDNA) variation and adverse drug reactions such as idiosyncratic drug-induced liver injury (iDILI). Here, we describe the generation of HepG2-derived transmitochondrial cybrids, to investigate the impact of mtDNA variation on mitochondrial (dys)function and susceptibility to iDILI. This study created 10 cybrid cell lines, each containing distinct mitochondrial genotypes of haplogroup H or haplogroup J backgrounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>HepG2 cells were depleted of mtDNA to make rho zero cells, before the introduction of known mitochondrial genotypes using platelets from healthy volunteers (n=10), thus generating 10 transmitochondrial cybrid cell lines. The mitochondrial function of each was assessed at basal state and following treatment with compounds associated with iDILI; flutamide, 2-hydroxyflutamide, and tolcapone, and their less toxic counterparts bicalutamide and entacapone utilizing ATP assays and extracellular flux analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Whilst only slight variations in basal mitochondrial function were observed between haplogroups H and J, haplogroup-specific responses were observed to the mitotoxic drugs. Haplogroup J showed increased susceptibility to inhibition by flutamide, 2-hydroxyflutamide, and tolcapone, via effects on selected mitochondrial complexes (I and II), and an uncoupling of the respiratory chain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs4\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study demonstrates that HepG2 transmitochondrial cybrids can be created to contain the mitochondrial genotype of any individual of interest. This provides a practical and reproducible system to investigate the cellular consequences of variation in the mitochondrial genome, against a constant nuclear background. Additionally, the results show that inter-individual variation in mitochondrial haplogroup may be a factor in determining sensitivity to mitochondrial toxicants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs5\">\n                    <jats:title>Funding:<\/jats:title>\n                    <jats:p>This work was supported by the Centre for Drug Safety Science supported by the Medical Research Council, United Kingdom (Grant Number G0700654); and GlaxoSmithKline as part of an MRC-CASE studentship (grant number MR\/L006758\/1).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7554\/elife.78187","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T15:00:14Z","timestamp":1686063614000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.78187","source":"Crossref","is-referenced-by-count":1,"title":["The generation of HepG2 transmitochondrial cybrids to reveal the role of mitochondrial genotype in idiosyncratic drug-induced liver injury"],"prefix":"10.7554","volume":"12","author":[{"given":"Amy Louise","family":"Ball","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xs57h96","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, University of Liverpool","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol E","family":"Jolly","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xs57h96","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, University of Liverpool","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G","family":"Lennon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01xsqw823","id-type":"ROR","asserted-by":"publisher"}],"name":"GSK, BioStatistics","place":["Stevenage, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J","family":"Lyon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01xsqw823","id-type":"ROR","asserted-by":"publisher"}],"name":"GSK, Safety Assessment","place":["Ware, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Alfirevic","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xs57h96","id-type":"ROR","asserted-by":"publisher"}],"name":"The Wolfson Centre for Personalised Medicine, Department Pharmacology and Therapeutics, University of Liverpool","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7399-8655","authenticated-orcid":true,"given":"Amy E","family":"Chadwick","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04xs57h96","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, University of Liverpool","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","DOI":"10.1186\/gm350","article-title":"In Silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA Archive from healthy volunteers","volume":"4","author":"Alfirevic","year":"2012","journal-title":"Genome Medicine"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1038\/sj.onc.1205983","article-title":"Mitochondrial stress-induced calcium signaling, Phenotypic changes and invasive behavior in human lung carcinoma A549 cells","volume":"21","author":"Amuthan","year":"2002","journal-title":"Oncogene"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1177\/1535370214531872","article-title":"In vitro platforms for evaluating liver toxicity","volume":"239","author":"Bale","year":"2014","journal-title":"Experimental Biology and Medicine"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/toxsci\/kfw126","article-title":"Identification of the additional mitochondrial liabilities of 2-Hydroxyflutamide when compared with its parent compound, Flutamide in Hepg2 cells","volume":"153","author":"Ball","year":"2016","journal-title":"Toxicological Sciences"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00204-021-02988-3","article-title":"Assessment of the impact of mitochondrial genotype upon drug-induced mitochondrial dysfunction in platelets derived from healthy volunteers","volume":"95","author":"Ball","year":"2021","journal-title":"Archives of Toxicology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1517\/14740338.2.3.263","article-title":"Hepatotoxic profile of Catechol-O-Methyltransferase inhibitors in Parkinson's disease","volume":"2","author":"Benabou","year":"2003","journal-title":"Expert Opinion on Drug Safety"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2165\/00003088-200443130-00003","article-title":"Bicalutamide: clinical pharmacokinetics and metabolism","volume":"43","author":"Cockshott","year":"2004","journal-title":"Clinical Pharmacokinetics"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1021\/tx7001349","article-title":"Comparison of the cytotoxicity of the Nitroaromatic drug Flutamide to its Cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using Toxicogenomic screening","volume":"20","author":"Coe","year":"2007","journal-title":"Chemical Research in Toxicology"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.drudis.2007.07.013","article-title":"The significance of mitochondrial toxicity testing in drug development","volume":"12","author":"Dykens","year":"2007","journal-title":"Drug Discovery Today"},{"key":"bib11","article-title":"European mtDNA Haplogroups frequency","volume-title":"Eupedia","author":"Eupedia","year":"2016","unstructured":"Eupedia. 2016. European mtDNA Haplogroups frequency. Eupedia."},{"key":"bib12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/1087057117696795","article-title":"Three-dimensional cell cultures in drug discovery and development","volume":"22","author":"Fang","year":"2017","journal-title":"SLAS Discovery"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.vascn.2018.09.002","article-title":"Challenges in designing and executing clinical trials in a dish studies","volume":"94","author":"Fermini","year":"2018","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","article-title":"Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives","volume":"146","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1039\/c6tx00101g","article-title":"Characterization of a functional C3A liver Spheroid model","volume":"5","author":"Gaskell","year":"2016","journal-title":"Toxicology Research"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007922","article-title":"The background of mitochondrial DNA Haplogroup J increases the sensitivity of Leber's hereditary optic neuropathy cells to 2,5-Hexanedione toxicity","volume":"4","author":"Ghelli","year":"2009","journal-title":"PLOS ONE"},{"key":"bib17","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.698825","article-title":"The role of mitochondrial DNA variation in drug response: A systematic review","volume":"12","author":"Jones","year":"2021","journal-title":"Frontiers in Genetics"},{"key":"bib18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2021.105096","article-title":"Investigating Dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models","volume":"72","author":"Jones","year":"2021","journal-title":"Toxicology in Vitro"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.tiv.2015.02.011","article-title":"The utility of Hepg2 cells to identify direct mitochondrial dysfunction in the absence of cell death","volume":"29","author":"Kamalian","year":"2015","journal-title":"Toxicology in Vitro"},{"key":"bib20","volume-title":"Biochemical Thermodynamic Modelling of Cellular Bioenergetics: A Quantitative Systems Pharmacology Approach","author":"Kelly","year":"2018"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/toxsci\/kfs326","article-title":"Use of Micropatterned Cocultures to detect compounds that cause drug-induced liver injury in humans","volume":"132","author":"Khetani","year":"2013","journal-title":"Toxicological Sciences"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1126\/science.2814477","article-title":"Human cells lacking mtDNA: Repopulation with exogenous mitochondria by Complementation","volume":"246","author":"King","year":"1989","journal-title":"Science"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1527-3458.2007.00035.x","article-title":"Evidence-based efficacy comparison of Tolcapone and Entacapone as Adjunctive therapy in Parkinson\u2019s disease","volume":"14","author":"Lees","year":"2008","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","article-title":"Drug-induced liver injury","volume":"89","author":"Leise","year":"2014","journal-title":"Mayo Clinic Proceedings"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/psp4.12053","article-title":"Elucidating differences in the hepatotoxic potential of Tolcapone and Entacapone with Dilisym((R)), a mechanistic model of drug-induced liver injury","volume":"5","author":"Longo","year":"2016","journal-title":"CPT"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"9705","DOI":"10.1073\/pnas.94.18.9705","article-title":"Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP Kinases","volume":"94","author":"Luo","year":"1997","journal-title":"PNAS"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2011.06.067","article-title":"Mitochondrial DNA as a non-invasive biomarker: accurate Quantification using real-time quantitative PCR without Co-amplification of Pseudogenes and dilution bias","volume":"412","author":"Malik","year":"2011","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1096\/fj.202000767R","article-title":"Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells","volume":"34","author":"Marchetti","year":"2020","journal-title":"FASEB Journal"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the Crabtree effect: replacing media glucose with Galactose increases susceptibility of Hepg2 cells to mitochondrial Toxicants","volume":"97","author":"Marroquin","year":"2007","journal-title":"Toxicological Sciences"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbabio.2014.10.005","article-title":"The contributions of respiration and Glycolysis to extracellular acid production","volume":"1847","author":"Mookerjee","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"key":"bib31","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.57.2.263","article-title":"Tolcapone and hepatotoxic effects","volume":"57","author":"Olanow","year":"2000","journal-title":"Archives of Neurology"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/wnf.0b013e318038d2b6","article-title":"Tolcapone: an efficacy and safety review","volume":"30","author":"Olanow","year":"2007","journal-title":"Clinical Neuropharmacology"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1042\/BST20190233","article-title":"Investigating the importance of individual mitochondrial genotype in susceptibility to drug-induced toxicity","volume":"48","author":"Penman","year":"2020","journal-title":"Biochemical Society Transactions"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1017\/s031716710000007x","article-title":"COMT inhibitors in Parkinson\u2019s disease","volume":"26 Suppl 2","author":"Rivest","year":"1999","journal-title":"The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nprot.2014.018","article-title":"Comprehensive measurement of respiratory activity in Permeabilized cells using extracellular flux analysis","volume":"9","author":"Salabei","year":"2014","journal-title":"Nature Protocols"},{"key":"bib36","volume-title":"Personal Communication","author":"Sch\u00e4fer","year":"2016"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/BF00615229","article-title":"The pharmacokinetics of Flutamide and its major metabolites after a single oral dose and during chronic treatment","volume":"34","author":"Schulz","year":"1988","journal-title":"European Journal of Clinical Pharmacology"},{"key":"bib38","first-page":"1298","article-title":"Metabolism of the Antiandrogenic drug (Flutamide) by human Cyp1A2","volume":"25","author":"Shet","year":"1997","journal-title":"Drug Metabolism and Disposition"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/toxsci\/kfv136","article-title":"Comparative Proteomic characterization of 4 human liver-derived single cell culture models reveals significant variation in the capacity for drug disposition, bioactivation, and Detoxication","volume":"147","author":"Sison-Young","year":"2015","journal-title":"Toxicological Sciences"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/onc.2015.227","article-title":"Disruption of cytochrome C oxidase function induces the Warburg effect and metabolic Reprogramming","volume":"35","author":"Srinivasan","year":"2016","journal-title":"Oncogene"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.nbd.2018.02.010","article-title":"Haplogroup J Mitogenomes are the most sensitive to the pesticide rotenone: relevance for human diseases","volume":"114","author":"Strobbe","year":"2018","journal-title":"Neurobiology of Disease"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/liv.13535","article-title":"Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy","volume":"38","author":"Tujios","year":"2018","journal-title":"Liver International"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.15698\/cst2018.10.158","article-title":"Mitochondrial stress management: a dynamic journey","volume":"2","author":"Valera-Alberni","year":"2018","journal-title":"Cell Stress"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"E386","DOI":"10.1002\/humu.20921","article-title":"Updated comprehensive Phylogenetic tree of global human mitochondrial DNA variation","volume":"30","author":"van Oven","year":"2009","journal-title":"Human Mutation"},{"key":"bib45","first-page":"S51","article-title":"COMT inhibitors and liver toxicity","volume":"55","author":"Watkins","year":"2000","journal-title":"Neurology"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41573-019-0048-x","article-title":"Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of Preclinical predictive models","volume":"19","author":"Weaver","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.redox.2014.03.006","article-title":"Cytoplasmic hybrid (Cybrid) cell lines as a practical model for Mitochondriopathies","volume":"2","author":"Wilkins","year":"2014","journal-title":"Redox Biology"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/78187\/elife-78187-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/78187\/elife-78187-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/78187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:04:18Z","timestamp":1697058258000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/78187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":47,"alternative-id":["10.7554\/eLife.78187"],"URL":"https:\/\/doi.org\/10.7554\/elife.78187","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.21.485109","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2022.03.21.485109","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.78187.sa2","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.78187.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.78187.sa0","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e78187"}}